Regeneron Pharmaceuticals, Inc.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$47.9M
Q ending 2026-03-31
Prior quarter
$33.8M
Q ending 2025-12-31
Change
+41.7% QoQ · -96.1% YoY
Positions
2
reported holdings
Largest positions
All 2 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Intellia Therapeutics, Inc. | NTLA | Shares | $47.5M | 3.7M |
| Adicet Bio, Inc. | TORCEUR | Shares | $412K | 61K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.